Clinical Trial Update: THromboprophylaxis In Sickle Cell Disease With Central Venous Catheters (THIS) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating thromboprophylaxis in sickle cell disease patients with central venous catheters has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Venous Catheter Thrombosis
• Sickle Cell Disease
• Venous Thromboembolism

Snippet

Sponsor: University Health Network, Toronto | Conditions: Sickle Cell Disease, Central Venous Catheter Thrombosis | Phase 3 | Status: TERMINATED